Arvee Laboratories (India) Ltd
Arvee Laboratories (India) Q2 Results 2026 (FY27) statement: Revenue & Margins
Q2 FY27 results statement: what the company reported on revenue, margins and capex.
Top 10 Chemicals & Petrochemicals companies on management guidance
See the sector's top 10 — free with your mobile number.
Arvee Laboratories (India) Ltd Q2 FY27 key numbers
- Revenue
- Revenue from Operations for the quarter ended September 30, 2026, is ₹2,492.81 Lakhs.
As stated in Arvee Laboratories (India) Ltd's Q2 FY27 results statement · published 3 Nov 2026. Reported figures, not investment advice.
Based on Arvee Laboratories (India) Ltd's Q2 FY27 results statement. The company has not published an earnings-call transcript for this quarter, so figures here are what the results statement reports, not management guidance.
The short version
Revenue from Operations for the quarter ended September 30, 2026, is ₹2,492.81 Lakhs (Page 5). EBITDA for the quarter ended September 30, 2026: ₹436.15 Lakhs, up 27% year-on-year from ₹343.17 Lakhs (Q2 FY25).
From Arvee Laboratories (India) Ltd's Q2 FY27 earnings-call transcript · updated 3 Nov 2026.
How did Arvee Laboratories (India)'s revenue grow in the September 2026 quarter?
- Revenue from Operations for the quarter ended September 30, 2026, is ₹2,492.81 Lakhs (Page 5).
- Revenue for the quarter ended September 30, 2025, was ₹345.05 Lakhs (Page 5).
- Year-on-year revenue growth for the quarter is approximately 622% [(2,492.81-345.05)/345.05 *100].
- The focus is on approved unaudited financial results and board changes without forward-looking statements regarding revenue or volumes.
What happened to Arvee Laboratories (India)'s margins in Q2 FY27?
See what Arvee Laboratories (India) Ltd said on profitability & margins — free account, 30 seconds.
What capex is Arvee Laboratories (India) planning?
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Is Arvee Laboratories (India) raising money or cutting debt?
See what Arvee Laboratories (India) Ltd said on fundraising & capital structure — free account, 30 seconds.
How big is Arvee Laboratories (India)'s order book?
See what Arvee Laboratories (India) Ltd said on order book & pipeline — free account, 30 seconds.
Arvee Laboratories (India) Ltd — Quarterly revenue & net profit
Q2 FY27 figures are not in this chart yet. Latest shown: Jun 2026 (Q1 FY27). The Q2 FY27 numbers from the filing are in the analysis on this page.
Reported quarterly figures (₹ Cr). Latest (Q1 FY27): revenue ₹17 Cr, net profit ₹2 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
Others in Chemicals & Petrochemicals this season
- Neptune Petrochemicals (Q2 FY27)
295.72 Lakhs, increased by 21% year-on-year. Key results statement takeaways from Neptune Petrochemicals Ltd's Q2 FY27 results statement — and how it ranks agai
- DIC India (Q2 FY27)
Revenue from sale of goods: ₹27,303.98 million . Key results statement takeaways from DIC India Ltd's Q2 FY27 results statement — and how it ranks against secto
- Linde India (Q2 FY27)
EBITDA: ₹1,887 million (though page 6 shows ₹1,881.54M) . Key results statement takeaways from Linde India Ltd's Q2 FY27 results statement — and how it ranks ag
- Kothari Petroche (Q2 FY27)
2,234.08 lakhs (approximately 15.6% increase) . Key results statement takeaways from Kothari Petrochemicals Ltd's Q2 FY27 results statement — and how it ranks a
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Arvee Laboratories (India) Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Arvee Laboratories (India) Ltd Q2 FY27 results?
Revenue from Operations for the quarter ended September 30, 2026, is ₹2,492.81 Lakhs (Page 5). EBITDA for the quarter ended September 30, 2026: ₹436.15 Lakhs, up 27% year-on-year from ₹343.17 Lakhs (Q2 FY25).
What is Arvee Laboratories (India) Ltd share price analysis?
Arvee Laboratories (India) Ltd currently shows a neutral. The stock trades at a P/E of 58.2 with a market cap of ₹236 Cr. Investors should review the full earnings analysis for detailed insights.
Keep Arvee Laboratories (India) Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's results statement. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.